Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Placenta tissue may speed healing of stubborn wounds

NCT ID NCT07375160

Disease control Sponsor: Cellution Biologics Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 28, 2026 · Updated 2 times

Summary

This study looks at how safe and effective a dehydrated human placenta tissue product is for healing chronic wounds like diabetic foot ulcers, venous leg ulcers, and pressure ulcers. Researchers will review medical records of 300 adults whose wounds were treated with this product. The main goal is to see how quickly the wounds close.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will be drawn from wound clinic patient population that previously received treatment of their wound with a Cellution Biologics dHPT product

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years of age or older. * Wound treated with Cellution Biologics AmchoPlast, a dehydrated human placental tissue (dHPT). * Wound present for greater than or equal to 30 days prior to treatment with dHPT. * Wound is not infected. * Wound surface area is greater than 1cm2 at initial assessment. * Clinical documentation of wound treatment. Exclusion Criteria: * AmchoPlast dHPT product was not applied to wound. * HbA1C \>12%. * Presence of active osteomyelitis. * Concurrent treatment for malignant disease. * Use of other advanced biologics during treatment period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetic foot ulcer (DFU) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

decubitus ulcer Diabetic Foot ulcer of lower limbs Varicose Ulcer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetic foot ulcer (DFU) Pressure ulcer (PU) Venous leg ulcer (VLU)

Contacts and locations

Locations

  • 001

    Chicago, Illinois, 60616, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.